Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionLipe & Dalton
Latest Disclosed Ownership800 shares
Latest Disclosed Value $ 49
Lipe & Dalton ownership in BRM / Bristol-Myers Squibb Company

On April 29, 2026 - Lipe & Dalton filed a 13F-HR form disclosing ownership of 800 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $41,936 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 800 shares of Bristol-Myers Squibb Company. The current value of the position is $37,948 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F Bristol Myers Squibb cs 110122108 800 0 0.00 0 0.0256
2026-01-26 2025-12-31 13F Bristol Myers Squibb cs 110122108 800 -1,150 -58.97 0 0.0212
2026-01-26 2025-09-30 13F Bristol Myers Squibb cs 110122108 1,950 -70 -3.47 0 0.0436
2025-08-01 2025-06-30 13F Bristol Myers Squibb cs 110122108 2,020 -54,979 -96.46 0 -100.00 0.0508
2025-05-05 2025-03-31 13F Bristol Myers Squibb cs 110122108 56,999 230 0.41 3 0.00 1.9451
2025-02-03 2024-12-31 13F Bristol Myers Squibb cs 110122108 56,769 208 0.37 3 50.00 1.7031
2024-11-04 2024-09-30 13F Bristol Myers Squibb cs 110122108 56,561 -590 -1.03 3 0.00 1.4781
2024-08-02 2024-06-30 13F Bristol Myers Squibb cs 110122108 57,151 -1,530 -2.61 2 -33.33 1.2763
2024-05-07 2024-03-31 13F Bristol Myers Squibb cs 110122108 58,681 450 0.77 3 50.00 1.6404
2024-01-30 2023-12-31 13F Bristol Myers Squibb cs 110122108 58,231 -470 -0.80 3 -33.33 1.6214
2023-11-03 2023-09-30 13F Bristol Myers Squibb cs 110122108 58,701 -190 -0.32 3 0.00 2.0505
2023-07-26 2023-06-30 13F Bristol Myers Squibb cs 110122108 58,891 -580 -0.98 4 -25.00 2.1459
2023-05-02 2023-03-31 13F Bristol Myers Squibb CS 110122108 59,471 -17,289 -22.52 4 -20.00 2.3614
2023-02-03 2022-12-31 13F Bristol Myers Squibb CS 110122108 76,760 -103 -0.13 6 -99.91 3.1777
2022-11-07 2022-09-30 13F Bristol Myers Squibb CS 110122108 76,863 101 0.13 5,464 -7.56 3.4268
2022-08-01 2022-06-30 13F Bristol Myers Squibb CS 110122108 76,762 -149 -0.19 5,911 5.23 3.4590
2022-04-26 2022-03-31 13F Bristol Myers Squibb CS 110122108 76,911 -523 -0.68 5,617 16.34 2.7420
2022-02-01 2021-12-31 13F Bristol Myers Squibb CS 110122108 77,434 1,216 1.60 4,828 7.05 2.2837
2021-11-01 2021-09-30 13F Bristol Myers Squibb cs 110122108 76,218 4,416 6.15 4,510 -6.00 2.3169
2021-08-02 2021-06-30 13F Bristol Myers Squibb CS 110122108 71,802 512 0.72 4,798 6.60 2.4943
2021-04-30 2021-03-31 13F Bristol Myers Squibb CS 110122108 71,290 76 0.11 4,501 1.90 2.4974
2021-01-29 2020-12-31 13F Bristol Myers Squibb CS 110122108 71,214 -324 -0.45 4,417 2.41 2.7157
2020-10-30 2020-09-30 13F Bristol Myers Squibb CS 110122108 71,538 -223 -0.31 4,313 2.20 2.9979
2020-08-07 2020-06-30 13F Bristol Myers Squibb cs 110122108 71,761 -1,279 -1.75 4,220 3.66 3.0641
2020-05-01 2020-03-31 13F Bristol Myers Squibb cs 110122108 73,040 -1,404 -1.89 4,071 -14.81 3.4439
2020-01-21 2019-12-31 13F Bristol Myers Squibb cs 110122108 74,444 3,676 5.19 4,779 33.16 3.1679
2019-11-07 2019-09-30 13F Bristol Myers Squibb cs 110122108 70,768 -2,328 -3.18 3,589 8.27 2.6201
2019-07-24 2019-06-30 13F Bristol-Myers Squibb cs 110122108 73,096 -353 -0.48 3,315 -5.39 2.3697
2019-04-30 2019-03-31 13F Bristol-Myers Squibb cs 110122108 73,449 -629 -0.85 3,504 -9.01 2.5774
2019-02-08 2018-12-31 13F Bristol-Myers Squibb cs 110122108 74,078 7,551 11.35 3,851 -6.76 3.1374
2018-11-05 2018-09-30 13F Bristol-Myers Squibb cs 110122108 66,527 -49 -0.07 4,130 12.11 2.8185
2018-08-06 2018-06-30 13F Bristol-Myers Squibb cs 110122108 66,576 -1,150 -1.70 3,684 -14.01 2.7098
2018-05-04 2018-03-31 13F Bristol-Myers Squibb cs 110122108 67,726 582 0.87 4,284 4.11 3.0642
2018-02-13 2017-12-31 13F Bristol-Myers Squibb cs 110122108 67,144 -1,005 -1.47 4,115 -5.27 2.8440
2017-11-03 2017-09-30 13F Bristol-Myers Squibb cs 110122108 68,149 940 1.40 4,344 15.99 3.0538
2017-08-08 2017-06-30 13F Bristol-Myers Squibb cs 110122108 67,209 5,030 8.09 3,745 10.77 2.4258
2017-05-08 2017-03-31 13F Bristol-Myers Squibb cs 110122108 62,179 2,730 4.59 3,381 -2.68 2.4468
2017-02-10 2016-12-31 13F Bristol-Myers Squibb cs 110122108 59,449 59,449 0.00 3,474 2.4712
2016-11-10 2016-09-30 13F Bristol-Myers Squibb cs 110122108 0 -2,305 -100.00 0 -100.00
2016-08-12 2016-06-30 13F Bristol-Myers Squibb cs 110122108 2,305 -150 -6.11 170 8.28 0.1174
2016-05-12 2016-03-31 13F Bristol-Myers Squibb COM 110122108 2,455 0 0.00 157 -7.10 0.1234
2016-02-10 2015-12-31 13F Bristol-Myers Squibb COM 110122108 2,455 2,455 169 0.1368
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.